Free Trial

Genus (LON:GNS) Share Price Crosses Above 200 Day Moving Average - Time to Sell?

Genus logo with Medical background

Shares of Genus plc (LON:GNS - Get Free Report) crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of GBX 1,831.17 ($23.84) and traded as high as GBX 2,115 ($27.53). Genus shares last traded at GBX 2,065 ($26.88), with a volume of 30,674 shares changing hands.

Analysts Set New Price Targets

Separately, Deutsche Bank Aktiengesellschaft reduced their target price on shares of Genus from GBX 2,300 ($29.94) to GBX 2,150 ($27.99) and set a "buy" rating on the stock in a report on Wednesday, July 17th.

Check Out Our Latest Report on GNS

Genus Stock Performance

The company has a current ratio of 1.80, a quick ratio of 1.08 and a debt-to-equity ratio of 53.54. The company's fifty day moving average is GBX 1,956.36 and its 200 day moving average is GBX 1,833.17. The company has a market cap of £1.30 billion, a P/E ratio of 16,500.00, a price-to-earnings-growth ratio of 2.87 and a beta of 0.37.

Genus Increases Dividend

The firm also recently announced a dividend, which will be paid on Friday, December 6th. Investors of record on Thursday, November 7th will be issued a dividend of GBX 21.70 ($0.28) per share. The ex-dividend date is Thursday, November 7th. This represents a dividend yield of 1.21%. This is a positive change from Genus's previous dividend of $10.30. Genus's dividend payout ratio (DPR) is currently 26,666.67%.

Insider Activity at Genus

In other news, insider Jorgen Kokke sold 2,186 shares of the firm's stock in a transaction dated Monday, September 16th. The shares were sold at an average price of GBX 1,956 ($25.46), for a total value of £42,758.16 ($55,660.19). In related news, insider Jorgen Kokke sold 2,186 shares of Genus stock in a transaction dated Monday, September 16th. The shares were sold at an average price of GBX 1,956 ($25.46), for a total transaction of £42,758.16 ($55,660.19). Also, insider Iain Ferguson purchased 3,000 shares of the stock in a transaction that occurred on Thursday, September 5th. The shares were acquired at an average cost of GBX 1,800 ($23.43) per share, with a total value of £54,000 ($70,294.19). 0.75% of the stock is owned by insiders.

About Genus

(Get Free Report)

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.

Read More

→ Tesla Execs are Freaking Out (From Angel Publishing) (Ad)

Should you invest $1,000 in Genus right now?

Before you consider Genus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genus wasn't on the list.

While Genus currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Netflix’s Bold Moves: 4 Strategies for Explosive Growth

Netflix’s Bold Moves: 4 Strategies for Explosive Growth

Netflix is shaking up the streaming world again with its new ad-supported tier, leading to a surge in subscribers and revenue.

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines